Paediatric Medicinal Products

NextPharma has the expertise and capability to support your paediatric product development strategy through a systematic approach geared to suit this product type. We can provide pharmaceutical product development expertise from Phase I clinical trials with scale-up capability to commercial scale production meeting FDA standards and all EU regulations.

Our product development experts understand the importance when developing paediatric medicinal products of working systematically through a Paediatric Investigation Plan (PIP). By doing this we can help you to ensure that all factors relevant to a paediatric formulation are considered right from the very outset. We are proud of our expertise in developing paediatric dosage forms, such as granules, pellets, mini-tablets and liquids, using only age range relevant excipients. We are aware of other important factors such as the palatability of the final dosage form and have extensive expertise in providing taste masking techniques. Where necessary we utilise an electronic tongue system as an analytical in vitro tool.